RelB sustains endocrine resistant malignancy: an insight of noncanonical NF-κB pathway into breast Cancer progression

被引：0
|
作者：
Mei Wang
Yanyan Zhang
Zhi Xu
Peipei Qian
Wenbo Sun
Xiumei Wang
Zhang Jian
Tiansong Xia
Yong Xu
Jinhai Tang
机构：
[1] The First Affiliated Hospital with Nanjing Medical University,Department of General Surgery
[2] Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University,Breast Disease Center
[3] The First Affiliated Hospital with Nanjing Medical University,Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment
[4] Nanjing Medical University,Department of Toxicology and Cancer Biology
[5] University of Kentucky Markey Cancer Center,undefined
来源：
Cell Communication and Signaling | / 18卷
关键词：
RelB; EMT; MMP1; Cancer progression and breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] RelB sustains endocrine resistant malignancy: an insight of noncanonical NF-κB pathway into breast Cancer progression
    Wang, Mei
    Zhang, Yanyan
    Xu, Zhi
    Qian, Peipei
    Sun, Wenbo
    Wang, Xiumei
    Jian, Zhang
    Xia, Tiansong
    Xu, Yong
    Tang, Jinhai
    CELL COMMUNICATION AND SIGNALING, 2020, 18 (01)
  • [2] The NFκB pathway and endocrine-resistant breast cancer
    Zhou, Y
    Eppenberger-Castori, S
    Eppenberger, U
    Benz, CC
    ENDOCRINE-RELATED CANCER, 2005, 12 : S37 - S46
  • [3] The noncanonical NF-κB pathway
    Sun, Shao-Cong
    IMMUNOLOGICAL REVIEWS, 2012, 246 : 125 - 140
  • [4] Noncanonical NF-κB in Cancer
    Tegowski, Matthew
    Baldwin, Albert
    BIOMEDICINES, 2018, 6 (02)
  • [5] Novel implemental roles of the NF-κB subunit RelB in osteoblastogenesis: intrinsic antagonism of the classical NF-κB pathway by RelB
    Hiasa, Masahiro
    Abe, Masahiro
    Matsumoto, Toshio
    Ishimaru, Naozumi
    JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28
  • [6] Downregulation of SAFB Sustains the NF-κB Pathway by Targeting TAK1 during the Progression of Colorectal Cancer
    Jiao, Hong-Li
    Ye, Ya-Ping
    Yang, Run-Wei
    Sun, Hui-Ying
    Wang, Shu-Yang
    Wang, Yong-Xia
    Xiao, Zhi-Yuan
    He, Liu-Qing
    Cai, Juan-Juan
    Wei, Wen-Ting
    Chen, Yan-Ru
    Gu, Chun-Cai
    Cai, Yue-Long
    Hu, Yun-Teng
    Lai, Qiu-Hua
    Qiu, Jun-Feng
    Liang, Li
    Cao, Guang-Wen
    Liao, Wen-Ting
    Ding, Yan-Qing
    CLINICAL CANCER RESEARCH, 2017, 23 (22) : 7108 - 7118
  • [7] Noncanonical NF-κB Signaling Pathway in Liver Diseases
    Chen, Qianhui
    Lu, Xinyu
    Zhang, Xiaoyong
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2021, 9 (01) : 81 - 89
  • [8] Expanding the Interactome of the Noncanonical NF-κB Signaling Pathway
    Willmann, Katharina L.
    Sacco, Roberto
    Martins, Rui
    Garncarz, Wojciech
    Krolo, Ana
    Knapp, Sylvia
    Bennett, Keiryn L.
    Boztug, Kaan
    JOURNAL OF PROTEOME RESEARCH, 2016, 15 (09) : 2900 - 2909
  • [9] MiR-449a promotes breast cancer progression by activating the NF-κB pathway
    Shi, Wei
    Lee, Matthew
    Kogo, Ryunosuke
    Bruce, Jeff
    How, Christine
    Yip, Kenneth W.
    Liu, Fei-Fei
    CANCER RESEARCH, 2014, 74 (19)
  • [10] Control of RelB during dendritic cell activation integrates canonical and noncanonical NF-κB pathways
    Shih, Vincent F-S
    Davis-Turak, Jeremy
    Macal, Monica
    Huang, Jenny Q.
    Ponomarenko, Julia
    Kearns, Jeffrey D.
    Yu, Tony
    Fagerlund, Riku
    Asagiri, Masataka
    Zuniga, Elina I.
    Hoffmann, Alexander
    NATURE IMMUNOLOGY, 2012, 13 (12) : 1162 - +
12345